Various natural metabolites such as quercetin, luteolin, and naringin can regulate key signaling pathways (such as MAPK, Nrf2, NF-κB) to promote cell apoptosis, exhibiting multi-target and multi-pathway characteristics, providing new ideas and strategies for the treatment of EMs. The gene discussed is NFKB1; the disease is eosinophilia-myalgia syndrome.